Genomtec (GMT.WA) Stock Price

Genomtec Price

GPW·CLOSED
2.44
​
Market closed

Over the last 7 years Genomtec grew revenue by 9.1% annually, reaching 21,000.00 PLN. For Genomtec, the net margin of -49,671.4% is down versus -3,248.9% a few years ago.

Genomtec stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genomtec business model & stock analysis

Genomtec SA generates revenue by researching and developing molecular diagnostic equipment, specifically focusing on the Genomtec ID mobile platform. This technology enables genetic diagnosis at the point of patient care, eliminating the need for complex laboratory workflows and qualified personnel. The platform is designed for use in primary care clinics, pharmacies, doctor’s offices, and hospital emergency departments.

Frequently asked questions about Genomtec

Converted at the current exchange rate, the Genomtec share trades at 0.56 EUR (2.44 PLN).

The Genomtec share (GMT.WA) is listed on 3 stock exchanges, including: Frankfurt (4VI.F).

The revenue cannot currently be calculated for Genomtec.

The profit cannot currently be calculated for Genomtec.

The P/E ratio cannot be calculated for Genomtec at the moment.

The P/S cannot be calculated for Genomtec currently.

The Eulerpool Quality Score for Genomtec is 3/10.

The ISIN of Genomtec is PLGNMTC00017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Genomtec is A2QRTZ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Genomtec is GMT.WA. The ticker symbol is used to trade Genomtec shares on the stock exchange.

Fair ValueTerminal
2.22 PLN
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website genomtec.com
Country
Poland
Currency
PLN
Initial public offering
Mar 17, 2021
ISIN
PLGNMTC00017
Cusip
X3079S102
Market capitalization
36.82 M PLNMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
4.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-94.52 %
Last updated Nov 10, 2026, 3:48 AM

Genomtec Peer Group

Genomtec Ticker

FRANKFURT · 4VI.FWARSAW · GMT.WAWSE · GMT.WA

Genomtec FIGI

GMT:PW · BBG00ZNLD9P9GMTPLN:EP · BBG00ZNLDD98GMTPLN:EZ · BBG00ZNLDDD3GMTPLN:XS · BBG00ZNLDDG0GMTPLN:XH · BBG00ZNLDDK5GMTPLN:XF · BBG00ZNLDDM3GMTPLN:XE · BBG00ZNLDDP0GMTPLN:XL · BBG00ZNLDDR8GMTPLN:XG · BBG00ZNLDDS7GMTPLN:XO · BBG00ZNLDDT6GMTPLN:XA · BBG00ZNLDDY0GMTPLN:XT · BBG00ZNLDF02

All fundamentals and in-depth analysis of Genomtec

Our stock analysis for Genomtec stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genomtec. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.